Conclusion on China Sample Clauses

Conclusion on China. Actually, the 1992 Amendment of Patent Law, has already reached the protection level of TRIPs. In addition, the pharmaceutical administrative protection regime protects foreign pharmaceutical patents granted between 1984 and 1993. So what China needs to consider now therefore is not how to comply with the TRIPs, but how to make use of the flexibility of the TRIPs to meet the public health concern is the big challenge to Chinese government. China has not made full use of the flexibility provisions in the TRIPs. Because Chinese scholars are eager to seek advanced standards of patent protection advocated by developed countries. And neglect the current specific situation in their own country. In the case of ADIS, until now, China has lagged behind developing-world nations -- among them India, South Africa and Brazil -- in challenging the world's pharmaceutical giants to cut prices for medicines to treat HIV, the virus that causes AIDS.254 This is the main point that why in China a Chinese patient with Aids is amount to be sentenced execution. But this situation is going to be changed. The majority of Chinese AIDS patients may soon be able to use a domestic version of a drug cocktail to treat their illness as domestic pharmaceutical firms begin to produce cheap, generic anti-HIV medicines. Last year, a little-known private company, Shanghai Xxxxxx Biopharmaceutical Co., applied to the country's State Drug Administration to generically produce two anti-HIV drugs known as ddI and d4T and plans to apply to make AZT, the first medicine approved to treat the HIV infection. And the state-owned Northeast General Pharmaceutical Factory says it has also applied to the government to make HIV drugs for domestic sale.255 But the result 254 Xxxxxx Xxxxx, Staff Reporter of The Wall Street Journal, Wall Street Journal - November 15, 2001, xxxx://xxx.xxxxx.xxx/news/wsj/2001/WJ011103.html. 255 The result has not come out. Unlike another AIDS drug, AZT, which was approved for domestic production by a different company last month, ddI is still under patent protection in China. Through changing the way a medicine is combined or other details of preparation, the applications don't violate the protections the medicines enjoy in China, explains Xxxxxxxx Xxxxxx'x Xx. Xx. "We are using a different formulation," said Xxx Xxx, general manager for the Beijing subsidiary of Shanghai Xxxxxx, which already manufactures the raw materials for AIDS drugs for export. "They use tablets, we use po...
Sample 1
AutoNDA by SimpleDocs

Related to Conclusion on China

  • Conclusion of Agreement 3.1. The Assignee confirms that it has familiarized itself with the Terms and Conditions of the Portal User and the terms and conditions of the Agreement, understands the rights and obligations arising therefrom and confirms that the terms and conditions thereof conform to the will of the Assignee.

  • Conclusione La presente Licenza resterà xxxxxx xxxx xxxx sua conclusione. Apple porrà termine automaticamente e senza preavviso ai diritti garantiti da questa Licenza in caso di inadempienza di qualsiasi xxxxxxx xxxxx Licenza stessa. In seguito alla conclusione di questa Licenza è fatto obbligo di interrompere l’utilizzo del Software Apple e di distruggere tutte le copie, totali o parziali, del medesimo. I paragrafi 3, 4, 5, 6, 7, 8, 10 e 11 della presente Licenza rimarranno validi anche dopo la conclusione della stessa.

  • Conclusion of the Agreement 1. All offers made by the Freight Forwarder are non-binding.

  • Conclusion of the contract 1. An Agreement is deemed to be concluded with the Contractor only after the Principal accepts an offer by the Contractor without reservations or if the Principal receives a written order confirmation from the Contractor or if the Contractor commences the provision of the service. If the Contractor issues a written order confirmation, such order confirmation is decisive in terms of content and scope of the Agreement unless expressly negotiated otherwise.

  • COOPERATION ON FRAUD 25.1. The Parties agree that they shall cooperate with one another to investigate, minimize and take corrective action in cases of fraud. The Parties’ fraud minimization procedures are to be cost effective and implemented so as not to unduly burden or harm one party as compared to the other.

  • CONCLUSION OF NEGOTIATIONS A. The State and MSEA-SEIU agree that this Agreement concludes all collective negotiations during its term. Neither party will during the term of this Agreement seek to unilaterally modify its terms through legislation or other means which may be available to them.

  • Limitation on Publication The Contractor shall not publish or submit for publication any article, press release, or other writing relating to the Contractor's services for the Judicial Council without prior review and written permission by the Judicial Council.

  • Evaluation of Tenders 33.1 The Procuring Entity shall use the criteria and methodologies listed in this ITT and Section III, Evaluation and Qualification criteria. No other evaluation criteria or methodologies shall be permitted. By applying the criteria and methodologies, the Procuring Entity shall determine the Lowest Evaluated Tender. This is the Tender of the Tenderer that meets the qualification criteria and whose Tender has been determined to be:

  • Cooperation on Safety The Employer and Union will cooperate in continuing and perfecting regulations which will afford adequate protection to employees engaged in hazardous areas.

  • Evaluation and Comparison of Tenders 2.24.1 The Procuring entity will evaluate and compare the tenders which have been determined to be substantially responsive, pursuant to paragraph 2.22

Time is Money Join Law Insider Premium to draft better contracts faster.